about
Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasisNon-viral infections in children after renal transplantationTransmission of Tropical and Geographically Restricted Infections during Solid-Organ TransplantationDiagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).Leishmania infantum chagasi in northeastern Brazil: asymptomatic infection at the urban perimeterLeishmania infantum leishmaniasis in corticosteroid--treated patients.Visceral leishmaniasis.Immunoblot analysis of the humoral immune response to Leishmania donovani polypeptides in cases of human visceral leishmaniasis: its usefulness in prognosis.Clinical and experimental advances in treatment of visceral leishmaniasis.Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages.The immunology of parasite infections in immunocompromised hosts.Leishmania and human immunodeficiency virus coinfection: the first 10 yearsL-Asparaginase as a new molecular target against leishmaniasis: insights into the mechanism of action and structure-based inhibitor design.Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine.Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovaniVisceral leishmaniasis in a patient with systemic lupus erythematosus.Inhibition of ABC transporters abolishes antimony resistance in Leishmania InfectionParasitic culture of buffy coat for diagnosis of visceral leishmaniasis in human immunodeficiency virus-infected patientsPyrexia, pancytopenia and macrophage inclusions in an elderly woman.Purification and characterization of an 80-kilodalton membrane protein from Leishmania donovaniHost factors in the severity of Q fever.Rare association of Visceral leishmaniasis with Hodgkin's disease: A case reportAllogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.Leishmaniasis in solid organ and hematopoietic stem cell transplant recipients.Immunoblot analysis of Leishmania panamensis antigens in sera of patients with American cutaneous leishmaniasis.Chitosan-based macrophage-mediated drug targeting for the treatment of experimental visceral leishmaniasis.Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.Recognition of Leishmania antigens by T lymphocytes from nonexposed individuals.Immune reactivity to fractionated Leishmania aethiopica antigens during coinfection with human immunodeficiency virus type 1.Leishmaniasis diagnosed from bronchoalveolar lavage.Seroprevalence of Leishmania infection among asymptomatic renal transplant recipients from southern Spain.Is Visceral Leishmaniasis Different in Immunocompromised Patients Without Human Immunodeficiency Virus? A Comparative, Multicenter Retrospective Cohort Analysis.Visceral leishmaniasis and HIV/AIDS in Brazil: Are we aware enough?HIV/AIDS-related visceral leishmaniasis: a clinical and epidemiological description of visceral leishmaniasis in northern Brazil.Parasitic infections in solid organ transplantation.Cytomegalovirus and Leishmania donovani coinfection in a renal allograft recipient.Localized lymphadenitis due to leishmania. Diagnosis by fine needle aspiration cytology.Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate.
P2860
Q24633365-6F7E5C73-E498-40B3-8E07-400C600F29A4Q26825208-7BD276B2-471C-46AE-B32A-CED25210FAF9Q27485255-AB453FF7-2662-4DAB-9C1D-D9E2E8D20F5FQ30275257-2C943B40-E446-4524-A63B-2FE1E32C052AQ30423076-0A7A5C0E-E3FD-4A1C-A82E-BA89E069CEB1Q33266943-90FA35FD-7075-4FD8-9481-632D52B1AB0DQ33565640-4A0F9995-969F-432F-A178-C65F361F7629Q33945073-E7C8637C-9097-4549-A151-F7C20A6AC413Q33982648-4C690DAA-4690-43FE-A258-D3B80A16E143Q34328882-255DFF66-481B-48B2-8C89-348436DEBA23Q34570535-E9FB2A7B-F05A-4056-9F5E-B4D7762245F9Q34648790-B6E2F38A-362A-48F1-9365-ECE8E4136742Q35029729-D162BC04-20B1-4BEB-8A80-C756602A6E92Q35374078-8530F54D-D5C4-4B9D-BAE3-DD9F10651D66Q35609857-A3B36DFE-A9E3-4B0D-A612-F811B6648951Q35817147-8AFA2DC2-8DBA-4CD9-BF2C-D59DE46A6E0CQ35851380-D04B2FC7-5B9D-47AE-B570-730C86B319D1Q36460404-00B5CE49-B632-4E3E-BC9A-C6298BBD55F3Q36482756-D0A38CE0-AD21-47A4-952B-61B6CE98213BQ36520830-31183335-B74F-4EB4-B448-A4489F688204Q36613400-331AB587-9E37-43DC-B4CE-A7A75FCFBCA7Q36999041-FF3AEF4A-0BEE-4953-B05C-1519590A6B80Q37944326-32DC396B-16EA-4978-8A53-6E65444ADBCEQ38917561-ACC7EFFE-9988-498F-AC85-B3FE0B58E624Q38995756-9D213239-5389-429B-B912-3736445B75D6Q38995842-9E2C6073-E526-4BE9-B412-226A90C86973Q39095407-5C0C5161-83A7-4196-9314-292A673C4987Q39547523-AA0C79EE-6B96-4B7C-AE79-08CD4160A8D6Q39820778-24B546D5-BD7E-451D-BE25-A9BD11E0BB6BQ40146818-384B3C71-5277-4172-A98F-5CA8C5D86D5DQ40185151-4E0BD69B-F3D6-4BDE-BEC9-6282AD773F1BQ40740029-E1D3679D-339F-4647-93CC-D730B9804433Q41044323-026638DA-E347-431E-BEE5-BA4165B88074Q41920983-BDC34331-3029-4FFA-B473-4D216D866A8DQ41930697-2138F71C-5BD8-419C-8BD9-6FE5979BB8F8Q42225232-F1594F43-2B8F-48B1-BF79-5CC9DEB36E97Q42272278-AFF3C48B-EECD-4537-B643-B73A08FADF6EQ42791447-A2013BAD-240F-4F9D-91A3-51D8AEBFF617Q43250325-40C330F1-FAF9-4BEB-84FF-1C14A35A84F7Q46425193-95D71283-E681-428F-A959-9B7C30C381C6
P2860
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Visceral leishmaniasis in immunocompromised hosts.
@en
type
label
Visceral leishmaniasis in immunocompromised hosts.
@en
prefLabel
Visceral leishmaniasis in immunocompromised hosts.
@en
P2093
P1476
Visceral leishmaniasis in immunocompromised hosts.
@en
P2093
C Montalbán
J M Aguado
M L Fernández-Guerrero
P304
P356
10.1016/0002-9343(87)90948-X
P407
P50
P577
1987-12-01T00:00:00Z